- Page 2282 | TalkMarkets

Content

All Posts > Content under
36497 to 36512 of 313907 Posts
<<< 1 ... 2280 2281 2282 2283 2284 ... 19620 >>>
China Launched The First CBDC Wallet Dispenser, With Disappointing Results
Article By: The Tokenist
Saturday, March 4, 2023 8:02 PM EDT
Demand for CBDC hard wallets in China has been disappointing so far, according to local reports.
In this article: CNY
Read
TFC: Dirt-Cheap Dividend Stock
Video By: Jason Fieber
Saturday, March 4, 2023 7:16 PM EDT
I want to share with you an opportunity I recently came across in shares of Truist Financial Corporation which appears to be trading at a significant discount. Check out the video for full details.
In this video: TFC
Watch
2023 Year-To-Date Percentage Returns Of 5 Largest U.S. Stocks - Saturday, March 4
Article By: David Kass
Saturday, March 4, 2023 6:30 PM EDT
The total market capitalization of the 5 largest U.S. companies equals around $7.1 trillion. Let's take a look at the numbers.
In this article: BRK-A, QQQ, AAPL, AMZN, MSFT, SPX, DJI, GOOGL
Read
Bear Market Returns Are Probably In Our Future
Article By: Terence Grennon
Saturday, March 4, 2023 5:49 PM EDT
The question is, given how high percentile valuations are, what should we expect will be the average equity returns over the next 10 years?
In this article: SPY
Read
Steel Stocks Are Quietly Leading This Market: Is It Too Late To Buy?
Article By: Zacks Investment Research
Saturday, March 4, 2023 5:11 PM EDT
Having suppressed economic activity for so long, analysts and investors are anticipating China’s economic activity to resume at a break-neck pace. One market that has benefited from this narrative more than most is the steel market.
In this article: NUE, STLD, ATI, MT, TX, ZEUS, TS, X
Read
Supercharge Your Trading With The 200-Day Moving Average Support Indicator
Article By: Deron Wagner
Saturday, March 4, 2023 4:40 PM EDT
Are you using the powerful 200-day moving average indicator in your trading strategy? If not, it’s time to start paying attention. Discover how the 200-day moving average has become a crucial “line in the sand.”
In this article: QQQ, SPY
Read
Forex And Cryptocurrencies Forecast - March 6-10
Article By: Roman Butko
Saturday, March 4, 2023 4:10 PM EDT
The GBP/USD currency pair has been in a sideways channel for the second week in a row. The range of its fluctuations exceeded 200 points, and the last chord of the week was placed in the middle of this channel.
In this article: FXE, FXB, FXY, UUP, BITCOMP
Read
Approaching A New Short-Term Uptrend
Article By: Douglas Gammons
Saturday, March 4, 2023 3:45 PM EDT
A hint at strength, combined with the favorable market action seen as we headed into the weekend, is making me optimistic that we are going to encounter a new rally.
In this article: JNK, OIL, PKB, VGK, NDX, SPX, VIX, DJI
Read
U.S. Weekly FundFlows Insight Report: Money Market Funds Attract $55.0 Billion, A Top 20 All-Time Weekly Total
Article By: Lipper Alpha Insight
Saturday, March 4, 2023 3:20 PM EDT
During the fund-flows week that ended March 2, 2023, investors were overall net purchasers of fund assets (including both conventional funds and ETFs) for the second week in three, adding a net of $38.8 billion.
In this article: IWM, NDX, SPX, VIX, DJI, BBEU, JEPI
Read
Buy/Sell: Wall Street's Top 10 Stock Calls This Week - Saturday, March 4
Article By: The Fly
Saturday, March 4, 2023 3:00 PM EDT
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street’s best analysts during the week of Feb. 27 through March 3.
In this article: COF, CRM, AMTX, DISH, NVDA, ZG, IHRT, ARNC, RIVN
Read
How It Started & How It's Going
Article By: John Mauldin
Saturday, March 4, 2023 2:40 PM EDT
We are still on the road to the Great Reset. We can better understand this by recalling the 2008 crisis, the policy responses to it, and decisions made through the 2010's. Let's look at that in-between history and how it brought us to this point.
Read
Week In Review: Abbisko Out-Licenses Rights To Precision NSCLC Medicine For $188 Million
Article By: ChinaBio® Today
Saturday, March 4, 2023 2:20 PM EDT
Abbisko Therapeutics out-licensed Greater China rights to a pre-clinical EGFR-TKI candidate for NSCLC to Allist Pharma in a $188 million deal. Also, Chipscreen Bio acquired greater China rights to a bispecific immunotherapy from Eucure Biopharma.
In this article: MRK
Read
US Jobs, Kuroda's Last BOJ Meeting, And Powell's Congressional Testimony Highlight The Week Ahead
Article By: Marc Chandler
Saturday, March 4, 2023 2:00 PM EDT
The dollar trended lower until the January jobs report and strong service ISM. These reports helped spur the greenback's recovery. However, we learned last week that auto sales and the service ISM prices paid decelerated in February.
In this article: FXE, FXA, FXB, FXC, FXY, UUP
Read
March 2023 Stock Considerations
Article By: Keith Park
Saturday, March 4, 2023 1:40 PM EDT
The calendar has turned, and a new trading month is upon us. 2023 is flying by as two months are already in the books, and that fact simply highlights the importance of staying invested in the stock market during both the good times and the bad.
In this article: GSK, LYB, T, VZ
Read
Quit The Stock Market And Buy Bonds
Article By: Marc Lichtenfeld
Saturday, March 4, 2023 1:32 PM EDT
Between 1802 and 2021, the worst 10 years for stocks showed a decline of 4.0%, while bonds dropped 5.4%. So why am I “quitting the stock market” in favor of bonds? In the short run, bonds, especially those of quality companies, are safer than stocks.
Read
Alkermes: Commercialization Program On Track, Sales Coming In Strong
Article By: MoneyShow.com
Saturday, March 4, 2023 1:10 PM EDT
The bigger biotechs have done a good job lately, with solid earnings to date. Speaking of which, Alkermes plc has recently exceeded estimates. Let's take a closer look at the company's performance.
In this article: ALKS
Read
36497 to 36512 of 313907 Posts
<<< 1 ... 2280 2281 2282 2283 2284 ... 19620 >>>